Reneo Pharmaceuticals Investors

29 investors on Angel Roster list Reneo Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Reneo Pharmaceuticals can appear together.

Investors listed
29
With verified email
38%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 29 Reneo Pharmaceuticals investors

The most complete profiles first. Showing 29 of 29.

  • Ed MathersVerified

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    Series BHealth CareE-commerceWomen FoundedEnterprise Software

    Portfolio: Rhythm Pharmaceuticals, Motus Therapeutics, Sentry, ObsEva and 15 more

    Verified email available

  • Ken HaasVerified

    Venture Capital, Advisor, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Sunny ReddyVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • andrew sinclairVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Aftab KheraniVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Andrew SchiffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more

    Verified email available

  • Eric AguiarVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Josh BilenkerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Robert WenzelVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Shelley ChuVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Tim HainesVerified

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Bali Muralidhar

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more

    Contact details available

  • Brian Gallagher, Jr.

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more

    Contact details available

  • Derek Rapp

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Isaac Zike Ph.D.

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Jay Schmelter

    Venture Capital, Founder, Private Equity Firm · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • John McKearn

    Venture Capital, Private Equity Firm, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Karen Spilizewski

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Kurt von Emster

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedInvestment ManagementLife Science

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Nancy Hong, PhD

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 37 more

    Contact details available

  • Tom Melzer

    Venture Capital, Founder, Investor · United States

    Series BSeries AHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix and 35 more

    Contact details available

  • Vin Miles

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Cookie Yu

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Amplyx Pharmaceuticals, Mirum Pharmaceuticals, OrphoMed, Allievex and 9 more

    Contact details available

  • Ford Worthy

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Amplyx Pharmaceuticals, Mirum Pharmaceuticals, OrphoMed, Allievex and 9 more

    Contact details available

  • John Heard

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Sarah Shackelton

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Scott Braunstein

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

  • Sophie Phillips

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

  • Tom Mathers

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Amplyx Pharmaceuticals, Mirum Pharmaceuticals, OrphoMed, Allievex and 9 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Reneo Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 29 Reneo Pharmaceuticals investors. 11 of them (38%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (28), Private Equity Firms (18) and Founder-Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Reneo Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Series B (8), Seed (7) and Pre-Seed (4).

Where are Reneo Pharmaceuticals investors based?

Most are based in the United States (24) and the United Kingdom (5).

Which companies have Reneo Pharmaceuticals investors backed?

The most-backed portfolio companies among them are Spruce Biosciences (25), Paratek Pharmaceuticals (18), GTx (18), Cytos (18) and Verona Pharma (18).

How do I contact Reneo Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 29, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.